Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis

NCT05758493 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Amyloidosis
Transthyretin Amyloidosis

Interventions

DIAGNOSTIC_TEST: 124I-Evuzamitide

Sponsor

Oregon Health and Science University

Collaborators

[object Object]
[object Object]